A Proposal by the U.S. Food and Drug Administration for Reliance on Single Institutional Review Boards: Proceed Only With Caution. Ann Intern Med 2024 Mar;177(3):383-384
Date
02/12/2024Pubmed ID
38346309DOI
10.7326/M23-2152Scopus ID
2-s2.0-85188479399 (requires institutional sign-in at Scopus site)Author List
Spellecy R, Thompson N, Nattinger ABAuthors
Ann B. Nattinger MPH, MD Vice Dean, Associate Provost, Professor in the Medicine department at Medical College of WisconsinRyan Spellecy PhD Assistant Provost, Director, Professor in the Institute for Health and Humanity department at Medical College of Wisconsin
Nathan Thompson MD Professor in the Pediatrics department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Ethics Committees, ResearchHumans
United States
United States Food and Drug Administration
